About Reshape Biotech
Reshape Biotech is a company based in Kongens Lyngby (Denmark) founded in 2018 by Daniel Storgaard and Carl-Emil Gron. Reshape Biotech has raised $29.23 million across 4 funding rounds from investors including FundersClub, 21st.BIO and Astanor. The company has 16 employees as of December 31, 2022. Reshape Biotech offers products and services including Ecosystem Discovery Platform, Imaging Device, and High-throughput Imaging Device. Reshape Biotech operates in a competitive market with competitors including Opentrons, Andrew Alliance, Transcriptic, MEGAROBO and Automata, among others.
- Headquarter Kongens Lyngby, Denmark
- Employees 16 as on 31 Dec, 2022
- Founders Daniel Storgaard, Carl-Emil Gron
-
Sectors
Industrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Reshape Aps
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$29.23 M (USD)
in 4 rounds
-
Latest Funding Round
$20 M (USD), Series A
Apr 09, 2024
-
Investors
FundersClub
& 9 more
-
Employee Count
16
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Reshape Biotech
Reshape Biotech offers a comprehensive portfolio of products and services, including Ecosystem Discovery Platform, Imaging Device, and High-throughput Imaging Device.
Captures and analyzes lab data for seamless sharing and insights.
Provides high-resolution plate imaging and incubation for experiments.
Enables scalable plate analysis and real-time data extraction.
People of Reshape Biotech
Unlock access to complete
Funding Insights of Reshape Biotech
Reshape Biotech has successfully raised a total of $29.23M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Reshape Biotech
Reshape Biotech has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include FundersClub, 21st.BIO and Astanor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Astanor is focused on transforming the agrifood system through investments.
|
Locked | Locked | Locked | |
|
Early-stage venture capital investments are made in critical industries.
|
Locked | Locked | Locked | |
|
Early-stage investments are directed toward disruptive technologies and innovations.
|
Locked | Locked | Locked |
Investor details for Reshape Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Reshape Biotech
Investment portfolio details for Reshape Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Reshape Biotech
Detailed financials for Reshape Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reshape Biotech Comparisons
Peer comparison for Reshape Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reshape Biotech
Reshape Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Opentrons, Andrew Alliance, Transcriptic, MEGAROBO and Automata, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pipetting robots for laboratory automation are developed.
|
|
| Locked | Locked | Locked |
Provider of automated liquid handling tools and software for scientific labs
|
|
| Locked | Locked | Locked |
Cloud-based robotic bio-lab services are delivered remotely for experiment execution.
|
|
| Locked | Locked | Locked |
Robotic solutions for industrial laboratory automation are provided by MEGAROBO.
|
|
| Locked | Locked | Locked |
Lab automation robots are provided for life sciences applications.
|
Detailed competitors of Reshape Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reshape Biotech
Complete news archive for Reshape Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reshape Biotech
Reshape Biotech was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Reshape Biotech is headquartered in Kongens Lyngby, Denmark. It is registered at Kongens Lyngby, Capital Region, Denmark.
Carl-Emil Gron is the current CEO of Reshape Biotech. They have also founded this company.
Reshape Biotech is a funded company, having raised a total of $29.23M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Reshape Biotech is 16.
Reshape Biotech was founded in 2018 in Kongens Lyngby, Denmark, within the biotechnology sector. Automated imaging and incubation capabilities are delivered through a scalable robotic platform, supporting data-driven decisions in microbiology research and development laboratories. Routine tasks are streamlined to enable emphasis on advanced research and collaboration efforts. Operations are centered on enhancing efficiency in scientific workflows.
Reshape Biotech's top competitors include Opentrons, Andrew Alliance and Automata.
Reshape Biotech offers Ecosystem Discovery Platform, Imaging Device, and High-throughput Imaging Device.
Reshape Biotech has 10 investors. Key investors include FundersClub, 21st.BIO, Astanor, R7 Partners, and ACME Capital.